| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 883 | 2021 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 275 | 2021 |
| Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma A Carpentier, F Laigle-Donadey, S Zohar, L Capelle, A Behin, A Tibi, ... Neuro-oncology 8 (1), 60-66, 2006 | 249 | 2006 |
| Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study A Carpentier, P Metellus, R Ursu, S Zohar, F Lafitte, M Barrie, Y Meng, ... Neuro-oncology 12 (4), 401-408, 2010 | 214 | 2010 |
| Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia E Raffoux, P Rousselot, J Poupon, MT Daniel, B Cassinat, R Delarue, ... Journal of clinical oncology 21 (12), 2326-2334, 2003 | 195 | 2003 |
| Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial X Duval, S van Der Werf, T Blanchon, A Mosnier, ... PLoS medicine 7 (11), e1000362, 2010 | 150 | 2010 |
| Phase II study of pembrolizumab as first-line, single-drug therapy for patients with unresectable cutaneous squamous cell carcinomas E Maubec, M Boubaya, P Petrow, M Beylot-Barry, N Basset-Seguin, ... Journal of Clinical Oncology 38 (26), 3051-3061, 2020 | 117 | 2020 |
| Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—a phase II multicentric, randomised study R Ursu, A Carpentier, P Metellus, V Lubrano, F Laigle-Donadey, ... European Journal of Cancer 73, 30-37, 2017 | 83 | 2017 |
| A Bacterial Biofilm in a Hemodialysis System Assessment of Disinfection and Crossing of Endotoxin FC VINCENT, AR TIBI, JC DARBORD ASAIO Journal 35 (3), 310-313, 1989 | 47 | 1989 |
| Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption J Blacher, S Czernichow, M Raphaël, C Roussel, ... The Journal of nutrition 137 (2), 373-378, 2007 | 40 | 2007 |
| Effect of oseltamivir, zanamivir or oseltamivir–zanamivir combination treatments on transmission of influenza in households F Carrat, X Duval, F Tubach, A Mosnier, S Van der Werf, A Tibi, ... Antiviral therapy 17 (6), 1085-1090, 2012 | 38 | 2012 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
| Immunotherapy with CpG‐ODN in neoplastic meningitis: A phase I trial R Ursu, S Taillibert, C Banissi, E Vicaut, O Bailon, E Le Rhun, JS Guillamo, ... Cancer science 106 (9), 1212-1218, 2015 | 36 | 2015 |
| Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial. E Maubec, M Boubaya, P Petrow, N Basset-Seguin, JJ Grob, B Dreno, ... Journal of Clinical Oncology 36 (15_suppl), 9534-9534, 2018 | 33 | 2018 |
| Prevalence of BSE in western France by screening cattle at risk: preliminary results of a pilot study D Calavas, C Ducrot, T Baron, E Morignat, JL Vinard, AG Biacabe, ... Veterinary Record 149 (2), 55-55, 2001 | 26 | 2001 |
| Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN. E Maubec, M Boubaya, P Petrow, N Basset-Seguin, JJ Grob, B Dréno, ... Journal of Clinical Oncology 37 (15_suppl), 9547-9547, 2019 | 25 | 2019 |
| A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers L Tennezé, V Daurat, A Tibi, P Chaumet‐Riffaud, C Funck‐Brentano British journal of clinical pharmacology 47 (1), 49-52, 1999 | 23 | 1999 |
| Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤ 40%) undergoing CABG … T Caruba, D Hourton, B Sabatier, D Rousseau, A Tibi, C Hoffart-Jourdain, ... Journal of Cardiothoracic Surgery 11, 1-7, 2016 | 20 | 2016 |
| Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group O Hermine, X Mariette, R Porcher, F Djossou, Y Nguyen, JB Arlet, ... EClinicalMedicine 46, 2022 | 19 | 2022 |
